Innovative Treatment Achieves 82% Success in Bladder Cancer Cure
TL;DR Summary
A new implant called TAR-200 has shown promising results in a phase 2 trial, eliminating tumors in 82% of high-risk bladder cancer patients resistant to previous treatments, with most tumors disappearing within three months and many patients remaining cancer-free after a year, offering a potentially safer and more effective alternative to traditional therapies.
- Tiny implant wipes out bladder cancer in 82% of patients ScienceDaily
- Some cancer patients could avoid surgery with innovative new therapy Fox News
- ��Most Effective Therapy to Date” – New Treatment Wipes Out Bladder Cancer in 82% of Patients SciTechDaily
- "Our goal is a solution for every bladder cancer patient" Johnson & Johnson
- Urologist describes early experience with gemcitabine intravesical system in NMIBC Urology Times
Reading Insights
Total Reads
0
Unique Readers
2
Time Saved
3 min
vs 4 min read
Condensed
92%
669 → 53 words
Want the full story? Read the original article
Read on ScienceDaily